VIVS Stock Analysis: Buy, Sell, or Hold?
VIVS - VivoSim Labs, Inc. Common Stock
$0.33
-0.01 (-2.90%)
βΌ
5d:
-14.16%
30d:
-65.86%
90d:
-76.76%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
6d
Get Alerted When VIVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: VIVS is down 14.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: VIVS is down 14.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: VIVS is currently trading at $0.33, which is considered oversold relative to its 30-day fair value range of $0.43 to $0.96.
Technical Outlook: Technically, VIVS is in a strong downtrend. Immediate support is located at $0.31, while resistance sits at $0.57.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VIVS is in a strong downtrend. Immediate support is located at $0.31, while resistance sits at $0.57.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.43 -
$0.96
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
74.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- WARNING: Recommendation downgraded due to -14.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.43 -
$0.96
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.31
Resistance Level
$0.57
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Revenue Growth (YoY)
-21.6%
Share & Embed Analysis
Last updated: August 03, 2026 10:44 PM ET
Data refreshes hourly during market hours. Next update: 11:44 PM
Data refreshes hourly during market hours. Next update: 11:44 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VIVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
ALNY
Alnylam Pharmaceuticals β¦ |
STRONG BUY
30 analysts |
$386 | 43 HOLD |
|
VRTX
Vertex Pharmaceuticals I⦠|
BUY
34 analysts |
$557 | 49 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals β¦ |
BUY
22 analysts |
$41 | 59 HOLD |